The Clorox Company (NYSE:CLX) Shares Sold by New York State Teachers Retirement System

New York State Teachers Retirement System decreased its position in The Clorox Company (NYSE:CLX - Free Report) by 3.1% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 94,956 shares of the company's stock after selling 3,024 shares during the period. New York State Teachers Retirement System owned about 0.08% of Clorox worth $13,982,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Y Intercept Hong Kong Ltd purchased a new position in Clorox during the fourth quarter worth approximately $285,000. QRG Capital Management Inc. grew its stake in Clorox by 64.0% in the 4th quarter. QRG Capital Management Inc. now owns 2,266 shares of the company's stock valued at $368,000 after acquiring an additional 884 shares during the period. SVB Wealth LLC purchased a new stake in Clorox in the 4th quarter worth $299,000. Fisher Asset Management LLC lifted its holdings in Clorox by 1.4% during the fourth quarter. Fisher Asset Management LLC now owns 26,427 shares of the company's stock valued at $4,292,000 after purchasing an additional 376 shares in the last quarter. Finally, Smartleaf Asset Management LLC grew its position in shares of Clorox by 33.1% in the fourth quarter. Smartleaf Asset Management LLC now owns 965 shares of the company's stock valued at $156,000 after purchasing an additional 240 shares during the period. Institutional investors and hedge funds own 78.53% of the company's stock.

Analyst Ratings Changes

Several research firms recently weighed in on CLX. JPMorgan Chase & Co. reduced their price target on shares of Clorox from $151.00 to $144.00 and set a "neutral" rating for the company in a research report on Tuesday, May 6th. Evercore ISI set a $140.00 price target on Clorox and gave the stock an "underperform" rating in a research report on Tuesday, May 6th. Wells Fargo & Company decreased their price objective on Clorox from $145.00 to $142.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. UBS Group dropped their target price on shares of Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a report on Thursday, April 17th. Finally, Citigroup cut their price objective on shares of Clorox from $165.00 to $150.00 and set a "neutral" rating for the company in a report on Monday, April 14th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, Clorox currently has a consensus rating of "Hold" and an average target price of $149.50.

Clorox Trading Up 0.1%

NYSE CLX traded up $0.14 during trading on Friday, hitting $124.80. The stock had a trading volume of 1,078,076 shares, compared to its average volume of 1,400,649. The company has a market capitalization of $15.38 billion, a PE ratio of 22.41, a PEG ratio of 3.03 and a beta of 0.51. The Clorox Company has a twelve month low of $117.35 and a twelve month high of $171.37. The company has a quick ratio of 0.44, a current ratio of 0.74 and a debt-to-equity ratio of 13.07. The firm has a 50 day moving average price of $129.92 and a 200 day moving average price of $144.13.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.45 earnings per share for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). The company had revenue of $1.67 billion for the quarter, compared to analysts' expectations of $1.74 billion. Clorox had a return on equity of 324.23% and a net margin of 9.89%. The firm's revenue was down 8.0% compared to the same quarter last year. During the same period in the prior year, the company posted $1.71 EPS. As a group, equities research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber bought 4,000 shares of the company's stock in a transaction that occurred on Wednesday, May 7th. The shares were purchased at an average price of $136.57 per share, with a total value of $546,280.00. Following the completion of the acquisition, the director directly owned 4,000 shares of the company's stock, valued at $546,280. This represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.57% of the stock is owned by corporate insiders.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.